Use of selective agonists for the estrogen receptor beta (ERP) mucositis induced by chemotherapy or radiation Cystitis and radiation induced

摘要

A method for treating or inhibiting mucositis or radiation Cystitis, using a selective ligand for ERbeta. Compositions, including Pharmaceutical compositions, containing the ERbeta Selective ligand and a traditional medicine for mucositis or radiation Cystitis.